Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

News and Press Releases

Read Veristat news and press releases to learn about our CRO service growth, geographic expansion in Europe and Asia, biotechnology preferred partnerships and small CRO acquisitions.

Veristat Launches Strategic Resourcing to Build Greater Flexibility in its Suite of Engagement Models

Providing sponsors expert staff to accelerate milestones and support study success

Veristat Expands its Expertise and Scale across Biopharma and Medtech

Acquires Swiss-based multi-disciplinary consultancy SFL (Solutions for Life Sciences) to accelerate...

Veristat Supported Marketing Applications for 12% of all FDA Novel Drug Approvals in 2021

Bridging the Gap between Trial and Treatment by Supporting the Approval of Several Novel Therapies...

Veristat Strengthens Regulatory Capabilities Across Europe and UK

Acquires Drug Development and Regulation (DDR), a regulatory consultancy led by former senior...

Veristat Appoints Colleen Pelton Chief Talent Officer

Global Talent Executive to Advance Company’s Commitment to a Best-in-class Workforce

Veristat Announces New Investment Partner—WindRose Health Investors

Recapitalization Will Accelerate Strategic Growth to Help Sponsors Save and Improve the Lives of...

Veristat Congratulates Origin Biosciences for FDA Approval

Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry during the Week of Rare...

Veristat Expands Biometrics Capabilities by Acquiring SQN Clinical

Builds on a shared pedigree of data management, statistics and programming excellence across all...

Veristat Supported Marketing Applications for 10% of all FDA Novel Drug Approvals in 2020

Strengthening its Track Record of Successful Client Regulatory Approval Outcomes

SOUTHBOROUGH, MA...

Veristat Launches Business Operations in Spain and Names Dr. Montserrat Barceló to Vice President, Europe

Leading the Organic and Acquisition Growth of Veristat Operations Throughout Europe

Veristat Named a Top Patient Recruitment Company by PharmaTech Outlook

Delivering A Patient-Centric Approach to Recruitment and Retention for Clinical Trials

...

Veristat Expands Pharmacovigilance and Safety Services with Acquisition of Certus PV

Delivering on Customer Demand for Pharmacovigilance from Clinical Trial Conduct to Post-Marketing...